Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$164.52 - $238.84 $7.87 Million - $11.4 Million
-47,839 Reduced 69.07%
21,420 $5.06 Million
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $9.18 Million - $10.3 Million
47,196 Added 213.91%
69,259 $13.6 Million
Q2 2023

Aug 14, 2023

SELL
$183.71 - $210.25 $775,991 - $888,096
-4,224 Reduced 16.07%
22,063 $4.64 Million
Q1 2023

May 11, 2023

BUY
$191.89 - $259.92 $3.21 Million - $4.35 Million
16,741 Added 175.37%
26,287 $5.31 Million
Q4 2022

Feb 10, 2023

SELL
$197.11 - $250.07 $496,914 - $630,426
-2,521 Reduced 20.89%
9,546 $2.08 Million
Q3 2022

Nov 07, 2022

BUY
$182.44 - $250.54 $1.74 Million - $2.38 Million
9,518 Added 373.4%
12,067 $2.38 Million
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $520,327 - $770,817
2,549 New
2,549 $545,000
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $1.09 Million - $1.4 Million
-3,116 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$372.64 - $458.3 $362,951 - $446,384
974 Added 45.47%
3,116 $1.29 Million
Q2 2021

Aug 03, 2021

SELL
$294.17 - $371.65 $377,420 - $476,826
-1,283 Reduced 37.46%
2,142 $792,000
Q1 2021

May 11, 2021

BUY
$249.67 - $299.48 $855,119 - $1.03 Million
3,425 New
3,425 $993,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.65B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Waratah Capital Advisors Ltd. Portfolio

Follow Waratah Capital Advisors Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waratah Capital Advisors Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Waratah Capital Advisors Ltd. with notifications on news.